← Back to Dashboard
Share:
QuantLogix
Quantitative Intelligence
WEEKLY MARKET BRIEFING
May 25 – 29, 2026
Published: May 29, 2026
Week in Review · W22 / 2026

A ninth straight win, a record Dow, and a month that belonged to AI infrastructure.

The S&P 500 closed out a holiday-shortened week with its ninth consecutive weekly gain — the longest streak since 2023 — while the Dow broke 51,000 for the first time ever and the Nasdaq notched a fresh record. The setup was deceptively heavy: April core PCE ran at 3.3% with headline PCE at a near three-year high of 3.8%, yet a softer underlying mix and an apparent U.S.–Iran ceasefire extension pulled crude back and steadied long yields. The week's signature was earnings, not macro. Dell ripped +33% after AI-server revenue exploded +757% and the company hiked its FY27 outlook by $25B+. Anthropic eclipsed OpenAI at a $965B valuation. Anduril and Palantir locked in $30B of combined Army enterprise ceilings. Biotech caught a late-week bid on a string of FDA approvals. Weekly tallies: S&P 500 +1.0%, Nasdaq +2.0%, Dow +0.9%; monthly: Nasdaq +8%, S&P +5%, Dow ~+3%.

Major Indices & Cross-Asset Snapshot

S&P 500
7,580.06
+1.0% W · +0.22% Fri
Nasdaq Comp.
26,972.62
+2.0% W · +0.20% Fri
Dow Jones
51,032.46
+0.9% W · +0.72% Fri · ATH
VIX
14.2
-6% W · complacent
UST 10Y
4.45%
+7 bps M · off recent highs
UST 2Y
3.98%
curve steepening
DXY (Dollar)
99.0
-0.6% W
Brent / WTI
$103.5 / $96
Iran de-escalation bid lifted
Bottom line

Breadth widened, volatility compressed, and the bid never left growth. Nine consecutive S&P weekly wins paired with a record Dow tell you the rally is no longer purely a Mag-7 trade — financials, industrials, and consumer cyclicals all participated. The risk is what's not on the tape: a 3.8% headline PCE print and a Fed leadership transition with hike risk priced at ~40% by year-end.

Sector Scoreboard · Week & Month

Sector (SPDR) Weekly May MTD YTD Driver
XLK Technology +2.4% +8.1% +22.3% Dell AI blowout; Nvidia $91B Q2 guide; Broadcom Q2 +47% acceleration
XLY Cons. Discretionary +1.4% +5.6% +8.1% Memorial Day spending steady; airline guidance reaffirmed
XLI Industrials +1.1% +4.2% +10.5% Defense primes firm; aerospace cycle still healthy
XLF Financials +0.9% +3.8% +9.4% Steeper curve + lower vol = bank multiple support
XLE Energy -0.6% -1.8% +30.4% Crude paid back Iran-risk premium; YTD leader still in place
XLV Health Care +1.3% +2.6% +4.1% FDA approval flurry; LLY momentum on Zepbound/Mounjaro
XBI Biotech (eq.-wt.) +2.7% +4.4% +5.7% Six May approvals; oncology + hep-D + hypertension catalysts
ITA Aerospace & Defense +0.8% +3.1% +12.6% Anduril $20B Army ceiling; Palantir $10B enterprise pact
XLU Utilities -0.4% -4.9% +2.1% AI-data-center grid stress narrative weighed all month
XLRE Real Estate +0.4% +1.6% +9.6% Long-end rate stabilization broadened relief rally

Earnings Spotlight · The Prints That Moved the Tape

Ticker Print Rev vs Cons. Reaction Takeaway
DELL Q1 FY27 $43.8B +88% YoY +33% AI server revenue +757% to $16.1B; $51.3B backlog; FY27 guide raised to $165–169B
NVDA Q1 FY27 (May 21) $81.6B +85% YoY Muted Record $58.3B profit; data center +92% to $75.2B; Q2 guide $91B vs $87B est
LLY Q1 2026 (early May) $19.80B +12% beat Steady EPS $8.55 vs $6.66 est; full-year guide raised $2B on Zepbound/Mounjaro
RTX Q1 (Apr 21) $22.1B +3% beat +3% EPS $1.78 vs $1.52; defense contract flurry sustained tape
AVGO Q2 guide (upcoming) ~$15.5B +47% YoY Pre-guided strength AI semi revenue track to $30B+ FY26; Google/Anthropic/Meta/OpenAI custom ASICs
Read-through

The Dell print is the more important tape signal than even Nvidia’s blowout: it confirms hyperscaler AI capex is being absorbed at the systems layer with margin intact, and the $51.3B backlog de-risks the second-half revenue ramp across the entire AI infrastructure stack — from accelerators (NVDA, AMD) to networking (AVGO, ANET) to power and cooling (VRT, ETN, SMCI).

Macro & Policy · The Cooler-Than-Feared PCE

Inflation · April PCE

Headline PCE accelerated to 3.8% YoY, the highest since May 2023, with core at 3.3%. The mix, though, was softer than feared after the energy shock — sticky services moderated and goods deflation persisted. Personal income growth slowed to 2.5%, real spending grew just +0.1%, and the savings rate fell to 2.6%.

Fed · Leadership Transition

The April 29 FOMC held at 3.50–3.75% with an extraordinary 8–4 split — the most dissents since 1992. It was Powell’s final meeting; Kevin Warsh has assumed the Chair. CME FedWatch now prices ~40% odds of a December hike (zero cuts in 2026) versus essentially 0% three months ago.

Labor · April Jobs

Nonfarm payrolls grew +115k, unemployment held at 4.3%. Gains concentrated in health care, transportation/warehousing, retail; federal employment continued to decline. Trailing 3-month average has slowed to ~75k vs ~167k in 2024 — cooling but not breaking.

Geopolitics · Iran De-escalation

The U.S. and Iran reportedly agreed in principle to a 60-day ceasefire extension and a path to nuclear negotiations, with potential unrestricted Strait of Hormuz transit. Brent has retraced from briefly above $110 to ~$103; the long-end UST yield is off its multi-decade highs but still elevated.

Policy stance

The Fed playbook for the rest of 2026 is now a function of three variables, not two: inflation persistence, labor durability, and the Warsh communications regime. Watch the June FOMC dot plot for confirmation that the new Chair is willing to let an above-target inflation print breathe in service of a softening labor market — or whether the four April dissenters become a hawkish majority.

Industry Deep Dive · Tech / AI / Defense / Biotech

Technology · AI Hardware
Bullish

XLK +8.1% MTD — second-best 2026 sector behind Energy. The thesis isn’t Nvidia anymore; it’s the full systems stack absorbing hyperscaler capex.

  • Dell (DELL): +33% Friday, +158% YTD; FY27 revenue guide raised to $165–169B
  • Nvidia (NVDA): $81.6B Q1, Q2 guide $91B, $80B buyback — the muted reaction is the tell that expectations have outrun even extraordinary delivery
  • Broadcom (AVGO): AI revenue tracking $30B+ FY26 across custom ASIC roster (Google, Anthropic, Meta, OpenAI, two undisclosed)
  • TSMC (TSM): +40% YoY revenue Q1; consensus » +30% growth FY26
Artificial Intelligence
Bullish

Private AI valuations cleared the trillion-dollar event horizon this week. The capital cycle is now self-reinforcing across model labs, infrastructure, and silicon.

  • Anthropic: raised $65B at $965B valuation (Altimeter / Dragoneer / Greenoaks / Sequoia lead, ea. >$2B); $47B run-rate revenue; Claude Opus 4.8 shipped
  • OpenAI: last marked at $730B; preparing confidential IPO filing
  • Hyperscaler capex: 10 GW of incremental data-center capacity contracted through 2027 across Broadcom’s AI customer set
  • Read-through: AI-data-center power demand is now the dominant rates-and-utilities story (XLU -4.9% MTD)
Defense · Primes & Defense Tech
Constructive

The Pentagon FY26 budget is $1.01T and the procurement model is bifurcating: primes for platforms, software-native firms for the kill chain.

  • Anduril: $5B Series H at $61B post; up-to-$20B 5–10yr Army enterprise ceiling consolidating ~125 prior orders
  • Palantir (PLTR): 10-year, up-to-$10B Army enterprise services pact rolling up ~75 prior contracts
  • RTX: Q1 beat; trading near $179, YTD +7% with a healthy contract pipeline
  • Northrop (NOC): $557, dividend reaffirmed; Citi cut PT to $628 (still Buy) — mixed but firming setup
  • Lockheed (LMT): ~25% off 2026 highs; first-mover discount opening for patient capital
Biotech · Pharma
Stock-Picker’s Tape

XBI (eq.-wt.) +5.7% YTD vs IBB (cap-wt.) -1.9% YTD — the breadth divergence flags a small/mid-cap discovery cycle, not a cap-weighted melt-up. May approvals were unusually heavy.

  • FDA approvals (May): Decnupaz (CD123 ADC, BPDCN), Hepcludex (hep-D), Baxfendy (aldosterone synthase inhibitor for hypertension — first-in-class), Immgolis (golimumab biosimilar), Trimbow (triple inhaler), Beqalzi (BCL-2 for r/r MCL)
  • Eli Lilly (LLY): Q1 EPS $8.55 vs $6.66; FY guide +$2B; $4B allocated to vaccine M&A — the GLP-1 cash flow now funding inorganic growth
  • Strong-buy technicals: AXSM, LNTH, CPRX leading scoring screens; LLY/NVO overbought but trending
  • Watch: H2 PDUFA cluster + FDA leadership posture under regulatory-flexibility regime — selective accelerated-approval bias intact

Looking Ahead · Week of June 1

Macro Calendar

ISM Manufacturing (Mon), JOLTS (Tue), ADP (Wed), ISM Services (Wed), Initial Claims (Thu), May Employment Situation (Fri, Jun 5) — the labor print is the dominant tape catalyst of the week.

Earnings & Events

CRWD, ZS, AVGO, DOCU headline a software-heavy slate; the Broadcom guide is the AI-acceleration confirmation/reset trigger. Watch for any pre-Jackson Hole signal from new Fed Chair Warsh.

What Would Break the Tape

A hot ECI / wage read, a defection by the four April dissenters toward an open hike call, or a re-acceleration in Brent above $108 on Iran-talks breakdown. Any one of these flips the rates path higher.

What Would Extend It

A <100k payrolls print with stable unemployment, AVGO confirming Q3 AI-revenue acceleration, and another quiet week on Iran. That is the Goldilocks setup that keeps the streak alive into double digits.

The QuantLogix Bottom Line

Nine consecutive S&P weekly wins, the Dow above 51,000 for the first time, and a Nasdaq +8% on the month — this is not a stealth rally anymore. It is a regime in which AI capex absorption, falling implied volatility, and a soft-landing labor mix are overwhelming a Fed that has lost two cut bets and gained a hike tail. The risk asymmetry has flipped: hedges are cheap, leadership is narrowing again at the index level even as breadth holds underneath, and the Fed transition adds policy variance that the options market is not yet pricing. We remain constructive on AI infrastructure (DELL, AVGO, NVDA, TSM), selectively long defense tech (PLTR, RTX) and primes at a discount (LMT), and tactical in biotech via XBI on the equal-weight breadth signal. Cash on the sidelines is a position too — not because we expect a drawdown, but because what’s priced in is now more than what’s reported.